PharmaEssentia sets up a new R&D facility in the Boston Area
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Acquisitions have the potential to add at least $1 billion in sales by 2028
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Miravo to remain a Canadian controlled and operated company following closing of the transaction
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
This will dramatically improve timely intervention with the right experts thus ensuring significant improvement in patient’s condition management and health outcome
Subscribe To Our Newsletter & Stay Updated